Last update 17 May 2025

VEGFR2 peptide vaccine(The University of Tokyo Hospital)

Overview

Basic Info

Drug Type
Shared antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine
Synonyms-
Target
VEGFR2
Action
modulators
Mechanism
VEGFR2 modulators(Vascular endothelial growth factor receptor 2 modulators)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Pancreatic Cancer
Inactive Indication
Colonic CancerRectal CancerRefractory Colorectal Carcinoma
Originator Organization
The University of Tokyo Hospital
Active Organization
The University of Tokyo Hospital
Inactive Organization
University of TokyoUniversity of Tokyo
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VEGFR2 peptide vaccine(The University of Tokyo Hospital)
NCT00677287
/ TerminatedPhase 1/2IIT
Phase I/II Study of Multiple-Vaccine Therapy Using Epitope Peptide Restricted to HLA-A*2402 in Combination With Tegafur/Uracil/Folinate in Treating Patients With Refractory Colorectal Cancer
100 Clinical Results associated with VEGFR2 peptide vaccine(The University of Tokyo Hospital)
Login to view more data
100 Translational Medicine associated with VEGFR2 peptide vaccine(The University of Tokyo Hospital)
Login to view more data
100 Patents (Medical) associated with VEGFR2 peptide vaccine(The University of Tokyo Hospital)
Login to view more data
100 Deals associated with VEGFR2 peptide vaccine(The University of Tokyo Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colonic CancerPhase 2
Japan
University of TokyoUniversity of Tokyo
01 May 2008
Rectal CancerPhase 2
Japan
University of TokyoUniversity of Tokyo
01 May 2008
Refractory Colorectal CarcinomaPhase 2
Japan
University of TokyoUniversity of Tokyo
01 May 2008
Pancreatic CancerPhase 1-
The University of Tokyo Hospital
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free